Menu

1 / 3

Biotech firms are meant to pay to use Earth’s genetic data. They’re not.

#nature#science#fund#biodiversity#genetic
Reading 0:00
15s threshold

Officials wave to participants as this year’s COP17 global biodiversity summit in Yerevan, Armenia, ends. Credit: Karen Minasyan/AFP via Getty

Two years ago, countries attending a United Nations biodiversity summit agreed that companies profiting from genetic data from Earth’s plants, animals and microbial life should pay a small percentage of their revenue to help preserve nature for future generations. But so far, only a handful of small biotechnology firms have contributed a total of just US$10,588.

‘A big, big win’: plan to pay for wildlife conservation emerges at biodiversity summit

Initial estimates indicated that it might be possible to collect a total of $1 billion per year from companies that use publicly available genetic data to create their products. Nobody knew that the actual amount gathered would be so much lower, says Amber Scholz, a microbiologist at the Leibniz Institute DSMZ in Braunschweig, Germany, who was involved in negotiating the Cali Fund, which takes in the money.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.